JAK2 and Hepatic fibrosis: Findings revealed that the specific deletion of CXCL14 in HSCs suppressed liver fibrosis in mice via the activating transcription factor 3 (ATF3)/CXCL14/RUNX1/JAK2 signalling pathway.